BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22503877)

  • 1. Serum lysophosphatidylcholine level is not altered in coronary artery disease.
    Song SH; Yoon Y; Park KU; Song J; Kim JQ
    Clin Biochem; 2012 Jul; 45(10-11):793-7. PubMed ID: 22503877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
    Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
    Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of lysophosphatidylcholines and phosphatidylcholines using liquid chromatography-tandem mass spectrometry in neonatal serum.
    Takatera A; Takeuchi A; Saiki K; Morisawa T; Yokoyama N; Matsuo M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):31-6. PubMed ID: 16603422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer.
    Zhao Z; Xiao Y; Elson P; Tan H; Plummer SJ; Berk M; Aung PP; Lavery IC; Achkar JP; Li L; Casey G; Xu Y
    J Clin Oncol; 2007 Jul; 25(19):2696-701. PubMed ID: 17602074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific enrichment of 2-arachidonoyl-lysophosphatidylcholine in carotid atheroma plaque from type 2 diabetic patients.
    Ménégaut L; Masson D; Abello N; Denimal D; Truntzer C; Ducoroy P; Lagrost L; Pais de Barros JP; Athias A; Petit JM; Martin L; Steinmetz E; Kretz B
    Atherosclerosis; 2016 Aug; 251():339-347. PubMed ID: 27189320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid profile in patients with coronary artery disease.
    Haddad FH; Omari AA; Shamailah QM; Malkawi OM; Shehab AI; Mudabber HK; Shubaki MK
    Saudi Med J; 2002 Sep; 23(9):1054-8. PubMed ID: 12370711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialic acid and oxidizability of lipid and proteins and antioxidant status in patients with coronary artery disease.
    Serdar Z; Yeşilbursa D; Dirican M; Sarandöl E; Serdar A
    Cell Biochem Funct; 2007; 25(6):655-64. PubMed ID: 17006879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate.
    Deutschman DH; Carstens JS; Klepper RL; Smith WS; Page MT; Young TR; Gleason LA; Nakajima N; Sabbadini RA
    Am Heart J; 2003 Jul; 146(1):62-8. PubMed ID: 12851609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
    Skoumas I; Masoura C; Pitsavos C; Tousoulis D; Papadimitriou L; Aznaouridis K; Chrysohoou C; Giotsas N; Toutouza M; Tentolouris C; Antoniades C; Stefanadis C
    Int J Cardiol; 2007 Oct; 121(2):178-83. PubMed ID: 17188767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma lipidomic analysis of stable and unstable coronary artery disease.
    Meikle PJ; Wong G; Tsorotes D; Barlow CK; Weir JM; Christopher MJ; MacIntosh GL; Goudey B; Stern L; Kowalczyk A; Haviv I; White AJ; Dart AM; Duffy SJ; Jennings GL; Kingwell BA
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2723-32. PubMed ID: 21903946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RANTES -403G>A promoter polymorphism in Korean men: association with serum RANTES concentration and coronary artery disease.
    Jang Y; Chae JS; Hyun YJ; Koh SJ; Kim JY; Ko MJ; Rim SJ; Shin HJ; Ordovas JM; Lee JH
    Clin Sci (Lond); 2007 Oct; 113(8):349-56. PubMed ID: 17504241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis.
    Stompór T; Pasowicz M; Sulłowicz W; Dembińska-Kieć A; Janda K; Wójcik K; Tracz W; Zdzienicka A; Klimeczek P; Janusz-Grzybowska E
    Am J Kidney Dis; 2003 Jan; 41(1):203-11. PubMed ID: 12500238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of lysophosphatidylcholine species by high-throughput electrospray ionization tandem mass spectrometry (ESI-MS/MS).
    Liebisch G; Schmitz G
    Methods Mol Biol; 2009; 580():29-37. PubMed ID: 19784593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine and lipid levels in young patients with coronary artery disease.
    Puri A; Gupta OK; Dwivedi RN; Bharadwaj RP; Narain VS; Singh S
    J Assoc Physicians India; 2003 Jul; 51():681-5. PubMed ID: 14621037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total and high molecular weight adiponectin in patients with coronary artery disease.
    El-Menyar A; Rizk N; Al Nabti AD; Hassira SA; Singh R; Abdel Rahman MO; Suwaidi JA
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):310-5. PubMed ID: 19430341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease--KOZANI STUDY.
    Kadoglou NP; Lampropoulos S; Kapelouzou A; Gkontopoulos A; Theofilogiannakos EK; Fotiadis G; Kottas G
    Transl Res; 2010 May; 155(5):238-46. PubMed ID: 20403579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.
    Falcone C; Emanuele E; D'Angelo A; Buzzi MP; Belvito C; Cuccia M; Geroldi D
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1032-7. PubMed ID: 15731496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidylcholine molecular species in low density lipoprotein of type 2 diabetes.
    Shi AH; Yoshinari M; Wakisaka M; Iwase M; Fujishima M
    Horm Metab Res; 1999 Apr; 31(4):283-6. PubMed ID: 10333086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine and progression of coronary artery disease.
    Skibińska E; Sawicki R; Lewczuk A; Prokop J; Musiał W; Kowalska I; Mroczko B
    Kardiol Pol; 2004 Mar; 60(3):197-205. PubMed ID: 15156215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.